Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume 25, Issue 5, Pages 699-708
Publisher
Springer Nature
Online
2012-02-03
DOI
10.1038/modpathol.2011.208
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Unique Spectrum of Somatic PIK3CA (p110α) Mutations Within Primary Endometrial Carcinomas
- (2011) Meghan L. Rudd et al. CLINICAL CANCER RESEARCH
- Pathologic Scoring of PTEN Immunohistochemistry in Endometrial Carcinoma is Highly Reproducible
- (2011) Karuna Garg et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- PIK3CA Mutations in Patients with Advanced Cancers Treated with PI3K/AKT/mTOR Axis Inhibitors
- (2011) F. Janku et al. MOLECULAR CANCER THERAPEUTICS
- High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability
- (2011) Lydia W.T. Cheung et al. Cancer Discovery
- A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma
- (2010) Brian M. Slomovitz et al. CANCER
- Loss of Inhibitory Insulin Receptor Substrate-1 Phosphorylation Is an Early Event in Mammalian Target of Rapamycin-Dependent Endometrial Hyperplasia and Carcinoma
- (2010) A. S. McCampbell et al. Cancer Prevention Research
- MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC)
- (2010) Ji-guang Zhang et al. CLINICA CHIMICA ACTA
- PI(3)King Apart PTEN's Role in Cancer
- (2010) S. Zhang et al. CLINICAL CANCER RESEARCH
- High-Grade Endometrial Carcinoma: Serous and Grade 3 Endometrioid Carcinomas Have Different Immunophenotypes and Outcomes
- (2010) Abdulmohsen Alkushi et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Correlation between PTEN expression and PI3K/Akt signal pathway in endometrial carcinoma
- (2010) Qinglei Gao et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Minor Serous and Clear Cell Components Adversely Affect Prognosis in ‘‘Mixed-Type’’ Endometrial Carcinomas: A Clinicopathologic Study of 36 Stage-I Cases
- (2010) M. Ruhul Quddus et al. Reproductive Sciences
- The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas
- (2009) K Shoji et al. BRITISH JOURNAL OF CANCER
- Altered PTEN expression; a diagnostic marker for differentiating normal, hyperplastic and neoplastic endometrium
- (2009) Soheila Sarmadi et al. Diagnostic Pathology
- Molecular alterations of EGFR and PIK3CA in uterine serous carcinoma
- (2009) Monica Prasad Hayes et al. GYNECOLOGIC ONCOLOGY
- AKT1 pleckstrin homology domain E17K activating mutation in endometrial carcinoma
- (2009) Yoram Cohen et al. GYNECOLOGIC ONCOLOGY
- A chemical screen in diverse breast cancer cell lines reveals genetic enhancers and suppressors of sensitivity to PI3K isoform-selective inhibition
- (2008) Neil E. Torbett et al. BIOCHEMICAL JOURNAL
- mTORC1 inhibitors: is temsirolimus in renal cancer telling us how they really work?
- (2008) C Le Tourneau et al. BRITISH JOURNAL OF CANCER
- PTEN-deficient cancers depend on PIK3CB
- (2008) S. Wee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation